About Index Trending news
Analyze
Pricing

Therapeutics

100+ Companies
Companies

Growing

157
Funding and Acquisitions

2016 Q4

22 + 2
Curators of Therapeutics
$25,000,000 Venture capital (Series A)
biocentury

Dauntless adds $25M to series A round

GeekWire , Xconomy

Seattle Genetics cancer drug clinical trials will go forward after FDA lifts hold

Seed fund
atriva-therapeutics , High-Tech Gründerfonds

Atriva Therapeutics GmbH - Atriva receives seed financing to develop its next generation influenza therapeutic

€1,600,000 Grant
BioVox - Life sciences Breakthroughs

Confo Therapeutics is awarded EUR 2.6M in non-dilutive funding

£14,000,000 Venture capital (Series A)
Cambridge Enterprise

Cambridge Enterprise joins in £14m funding round for spin-out ApcinteX Limited

€15,000,000 Venture capital
Silicon Republic , The Irish Times

Galway medtech firm Atlantic Therapeutics raises €15m

BetaKit

Today in funding ($17.8M): Appili Therapeutics, Enbala Power Network, Sofdesk

Funding Energy Apps & Services
GeekWire

UW biotech spinout DMD Therapeutics raises $400k to pursue treatment for rare form of muscular dystrophy

$400,000 Seed fund
FinSMEs

Biotech Startup DMD Therapeutics Receives Funding

$10,000,000 Venture capital (Series A)
GeekWire

Nativis raises $10M for device that uses electromagnetic fields to mimic the effects of cancer drugs

$3,547,395 Venture capital
biospace

Modus Raises SEK 32 Million To Support Development Of Sevuparin For Sickle Cell Disease

Grant
socaltech

Neuropore Therapies Gets Grant From Michael J. Fox Foundation

$2,800,000 Grant
businesswire

Appili Therapeutics Awarded $2.8M From ACOA to Fund Clinical Trials

Xconomy

Seattle Genetics Puts Up $250M for Immunomedics Cancer Drug Rights

GeekWire

Inside Nohla Therapeutics’ new Seattle biotech lab as Gov. Jay Inslee geeks out on science

PE Hub

Vividion Therapeutics picks up $50 mln Series A - PE Hub

Funding Messaging
$50,000,000 Venture capital (Series A)
businesswire

Vividion Therapeutics, Inc., Launches With $50 Million Series A Financing

PE Hub

Biscayne Neurotherapeutics scores $3 mln Series B - PE Hub

$3,000,000 Venture capital (Series B)
FinSMEs

Biscayne Neurotherapeutics Raises over US$3M in Series B Funding

$2,800,000 Venture capital
FinSMEs

Fibrocor Therapeutics Raises CDN$2.8m in Funding